NCT02021097

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

A Multicenter, Randomized, Open-labe, Controlled Study to Evaluate the Efficacy and Safety of the Combined Levonorgestrel(LNG) 100mcg and Ethinyl Estradiol(EE) 20mcg for Oral Contraception

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,008 (estimated)
• Sponsor: Regenex Pharmaceutical, China · Academic / Other
• Sex: Female
• Age: 20 Years – 35 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the contraceptive efficacy and safety of an oral contraceptive containing a combination of LNG 100mcg/EE 20mcg compared to LNG 150mcg/EE 30 mcg.

Conditions

• Oral Contraceptive

Interventions

Type	Name	Description
DRUG	Levonorgestrel 100 mcg and Ethinyl Estradiol 20 mcg	Tablet, orally, opd
DRUG	Levonorgestrel 150 mcg and Ethinyl Estradiol 30 mcg	Tablet, orally, opd

Timeline

• Start date: 2012-02-01
• Primary completion: 2015-02-01
• Completion: 2016-02-01
• First posted: 2013-12-27
• Last updated: 2013-12-27

Locations

21 sites across 1 country: China